Biomarkers for Parkinson’s disease and Alzheimer’s disease

Biomarkers for Parkinson’s disease and Alzheimer’s disease

<p>Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) represent the two most prevalent neurodegenerative diseases in the world, affecting 30 million and 5 million people, respectively. As populations age, the global burden of AD and PD will increase, resulting in significant societal and ec...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Liu, B
Awduron Eraill:	Lovestone, S
Fformat:	Traethawd Ymchwil
Cyhoeddwyd:	2018

Eitemau Tebyg

Peripheral biomarkers for early detection of Alzheimer's and Parkinson's diseases
gan: Htike, Thein Than, et al.
Cyhoeddwyd: (2020)

Working memory in Alzheimer's disease and Parkinson's disease
gan: Zokaei, N, et al.
Cyhoeddwyd: (2019)

Complement biomarkers as predictors of disease progression in Alzheimer's disease.
gan: Hakobyan, S, et al.
Cyhoeddwyd: (2016)

Imaging and biomarkers for Alzheimer's disease.
gan: Allan, C, et al.
Cyhoeddwyd: (2010)

Biomarkers for Alzheimer's disease therapeutic trials
gan: Hampel, H, et al.
Cyhoeddwyd: (2010)

Biomarkers for Alzheimer's disease therapeutic trials.
gan: Hampel, H, et al.
Cyhoeddwyd: (2011)

Inflammatory biomarkers in Alzheimer's disease plasma
gan: Morgan, A, et al.
Cyhoeddwyd: (2019)

A systematic review of biomarkers for disease progression in Parkinson's disease.
gan: McGhee, D, et al.
Cyhoeddwyd: (2013)

Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism.
gan: Greenfield, S, et al.
Cyhoeddwyd: (2002)

Clinical and neuroimaging biomarkers of early and prodromal Parkinson's disease
gan: Rolinski, M
Cyhoeddwyd: (2017)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
gan: Baird, A, et al.
Cyhoeddwyd: (2015)

Shape-Attributes of Brain Structures as Biomarkers for Alzheimer’s Disease
gan: Glozman, Tanya, et al.
Cyhoeddwyd: (2017)

Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
gan: Winchester, LM, et al.
Cyhoeddwyd: (2023)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
gan: Delvenne, A, et al.
Cyhoeddwyd: (2024)

[Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation]
gan: Ebmeier, K, et al.
Cyhoeddwyd: (1988)

Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus.
gan: Smith, M, et al.
Cyhoeddwyd: (2000)

Application of graph convolutional neural networks to Alzheimer's and Parkinson's disease classification
gan: Goli, Haveesh
Cyhoeddwyd: (2021)

D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.
gan: Kashiwaya, Y, et al.
Cyhoeddwyd: (2000)

Predictive ability of cerebrospinal fluid biomarkers in diagnosing and evaluating Parkinson's disease
gan: Wang, Michelle J
Cyhoeddwyd: (2014)

Colonic mucosal -synuclein lacks specificity as a biomarker for Parkinson disease
gan: Ruffmann, C, et al.
Cyhoeddwyd: (2015)

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
gan: Guella, I, et al.
Cyhoeddwyd: (2016)

Innovative Alzheimer's disease clinical trial design in the coming age of biomarkers
gan: Hillerstrom, Hampus
Cyhoeddwyd: (2010)

Blood-based ATN biomarkers of Alzheimer’s disease: a meta-analysis
gan: Koychev, I, et al.
Cyhoeddwyd: (2021)

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease
gan: Ahmad, S, et al.
Cyhoeddwyd: (2020)

Different patterns of short-term memory deficit in Alzheimer's disease, Parkinson's disease and subjective cognitive impairment
gan: Zokaei, N, et al.
Cyhoeddwyd: (2020)

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
gan: Compta, Y, et al.
Cyhoeddwyd: (2011)

Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains
gan: Dobricic, V, et al.
Cyhoeddwyd: (2022)

Parkinson's disease
gan: Behrman, S, et al.
Cyhoeddwyd: (2015)

Detection of alzheimer's disease biomarkers and my cot oxins using spectroscopic ellipsometry
gan: Mustafa, Mohd Kamarulzaki
Cyhoeddwyd: (2011)

Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
gan: Dan Yuet Ruh
Cyhoeddwyd: (2024)

Correlation of Alzheimer’s Disease neuropathologic staging with amyloid and tau scintigraphic imaging biomarkers
gan: Koychev, I, et al.
Cyhoeddwyd: (2020)

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
gan: Guerreiro, R, et al.
Cyhoeddwyd: (2015)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
gan: Winchester, L, et al.
Cyhoeddwyd: (2022)

Neuropathology of Alzheimer's Disease
gan: Gomez-Isla, T, et al.
Cyhoeddwyd: (2008)

Towards the identification of Idiopathic Parkinson’s Disease from the speech. New articulatory kinetic biomarkers
gan: Moro-Velázquez, L., et al.
Cyhoeddwyd: (2018)

Investigating the viability of motoric task performance as a clinical biomarker in Huntington’s and Parkinson’s disease
gan: Jayaraj, MS
Cyhoeddwyd: (2014)

Neddylation dysfunction in Alzheimer's disease
gan: Chen, Yuzhi, et al.
Cyhoeddwyd: (2014)

Dementia in Parkinson’s disease
gan: Hu, M, et al.
Cyhoeddwyd: (2020)

Current and future trends in biomarkers for the early detection of Alzheimer's disease in Asia: expert opinion
gan: Kandiah, Nagaendran, et al.
Cyhoeddwyd: (2024)

Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?
gan: Merlo Pich, E, et al.
Cyhoeddwyd: (2014)